Featured Research

from universities, journals, and other organizations

Chemical Warfare Ravages Mental Health Of Iranian Civilians

Date:
August 1, 2006
Source:
Yale University
Summary:
Iranian civilians exposed to high-intensity warfare and chemical weapons are experiencing significantly higher levels of psychological distress compared to those exposed to low-intensity warfare but not chemical weapons, researchers at Yale School of Medicine report in the August 2 issue of the Journal of the American Medical Association devoted to the theme of violence and human rights.

Iranian civilians exposed to high-intensity warfare and chemical weapons are experiencing significantly higher levels of psychological distress compared to those exposed to low-intensity warfare but not chemical weapons, researchers at Yale School of Medicine report in the August 2 issue of the Journal of the American Medical Association devoted to the theme of violence and human rights.

The research was based on data collected in July 2004 on 153 civilians in three towns bordering Iran and Iraq by researchers in the Department of Epidemiology and Public Health (EPH) at Yale School of Medicine, the Department of Psychiatry and the VA Connecticut Healthcare System.

The team, led by EPH research associate Farnoosh Hashemian, conducted a cross-sectional randomized study to measure civilian trauma during the Iran-Iraq war, which lasted from 1980 to 1988, caused one million casualties on both sides and 60,000 chemical warfare survivors in Iran. While much is known about the physical consequences of chemical warfare, the researchers sought to document the long-term effects of chemical attacks on mental health.

During two months in Iran, the team examined war-related mental health problems in three towns. One town was exposed to conventional low-intensity warfare, another was exposed to high-intensity warfare and the third, Sardasht, was exposed to both high-intensity warfare and chemical warfare. The team conducted 90-minute face-to-face interviews with residents and measured post-traumatic stress disorder (PTSD), anxiety and depression.

Those who were exposed to both high-intensity warfare and chemical weapons had significantly higher mental health disorders than did residents of the other two towns. Fifty-nine percent of Sardasht residents were found to have experienced PTSD in their lifetime. Thirty-three percent were currently suffering from PTSD, 65 percent reported major anxiety symptoms and 41 percent had severe depressive symptoms.

The study showed that depression, anxiety and PTSD are also prevalent among residents in the high-intensity warfare town. Thirty-one percent had lifetime PTSD, eight percent had current PTSD, 25 percent had major anxiety symptoms and 12 percent had severe depressive symptoms.

"Our results highlight the importance of examining long-term mental health problems in communities affected by war, particularly in those exposed to chemical weapons," said Hashemian, who was herself raised in Iran and witnessed the suffering caused by war and chemical warfare. "Survivors of chemical warfare need access to a variety of resources to recover from the trauma that happened 17 years ago. We hope this study raises awareness about the horrifying effects of the use of chemical weaponry and demonstrates the urgent need for a stronger international commitment to destruction of such weapons."

Hashemian said that at the time of the mustard gas attack, the residents assumed it was another conventional weapon bombardment. In a few hours, however, people experienced temporary blindness, shortness of breath, coughing, vomiting and severe blisters. Serious skin burns, eye damage and respiratory symptoms are the most common chronic health problems experienced by survivors of chemical warfare. "These physical wounds are being treated in those who survived, but now we have to focus our attention on treating the mental wounds," she said.

The study was strongly supported by Janbazan Medical and Engineering Research Center, which is primarily responsible for providing health and human services and coordinating government activities affecting war veterans and chemical attack survivors in Iran.

Other authors on the study included Kaveh Khoshnood, Mayur M. Desai, Farahnaz Falahati, M.D., Stanislav Kasl and Steven Southwick Southwick, M.D.

Citation: JAMA, Vol. 296 No. 5, (August 2, 2006).


Story Source:

The above story is based on materials provided by Yale University. Note: Materials may be edited for content and length.


Cite This Page:

Yale University. "Chemical Warfare Ravages Mental Health Of Iranian Civilians." ScienceDaily. ScienceDaily, 1 August 2006. <www.sciencedaily.com/releases/2006/08/060801230513.htm>.
Yale University. (2006, August 1). Chemical Warfare Ravages Mental Health Of Iranian Civilians. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2006/08/060801230513.htm
Yale University. "Chemical Warfare Ravages Mental Health Of Iranian Civilians." ScienceDaily. www.sciencedaily.com/releases/2006/08/060801230513.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins